These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 35506599)
1. Impact of Selected Initial Titration Schedules on Safety and Long-Term Effectiveness of Lamotrigine for the Treatment of Mood Disorders. Nakamura T; Tomita M; Hirota S; Matsunaga T; Uchimura N J Clin Psychopharmacol; 2022 Jul-Aug 01; 42(4):350-356. PubMed ID: 35506599 [TBL] [Abstract][Full Text] [Related]
2. Lamotrigine-induced rash--worth a rechallenge. P-Codrea Tigaran S; Sidenius P; Dam M Acta Neurol Scand; 2005 Mar; 111(3):191-4. PubMed ID: 15736314 [TBL] [Abstract][Full Text] [Related]
3. Predictors of Lamotrigine-associated rash. Hirsch LJ; Weintraub DB; Buchsbaum R; Spencer HT; Straka T; Hager M; Resor SR Epilepsia; 2006 Feb; 47(2):318-22. PubMed ID: 16499755 [TBL] [Abstract][Full Text] [Related]
4. Rash during lamotrigine treatment is not always drug hypersensitivity: A retrospective cohort study among children and adults. Shirzadi M; Saunes M; Reimers A; Brodtkorb E Seizure; 2021 Jul; 89():12-18. PubMed ID: 33951602 [TBL] [Abstract][Full Text] [Related]
5. Risk of a lamotrigine-related skin rash: current meta-analysis and postmarketing cohort analysis. Wang XQ; Xiong J; Xu WH; Yu SY; Huang XS; Zhang JT; Tian CL; Huang DH; Jia WQ; Lang SY Seizure; 2015 Feb; 25():52-61. PubMed ID: 25645637 [TBL] [Abstract][Full Text] [Related]
6. The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial. Ketter TA; Greist JH; Graham JA; Roberts JN; Thompson TR; Nanry KP J Clin Psychiatry; 2006 Mar; 67(3):400-6. PubMed ID: 16649826 [TBL] [Abstract][Full Text] [Related]
8. Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome). Donaldson JA; Glauser TA; Olberding LS Epilepsia; 1997 Jan; 38(1):68-73. PubMed ID: 9024186 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the retention rate, safety, and efficacy of two different titration protocols for lamotrigine in newly diagnosed epilepsy patients. Zhang N; Yang D; Niu C; Li P; Wang H; Li X; Jing W Expert Rev Neurother; 2022; 22(11-12):1025-1029. PubMed ID: 36460011 [TBL] [Abstract][Full Text] [Related]
10. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. Frye MA; Ketter TA; Kimbrell TA; Dunn RT; Speer AM; Osuch EA; Luckenbaugh DA; Cora-Ocatelli G; Leverich GS; Post RM J Clin Psychopharmacol; 2000 Dec; 20(6):607-14. PubMed ID: 11106131 [TBL] [Abstract][Full Text] [Related]
11. [Lamotrigine in bipolar disorder: preventing depression to treat the disease]. Cuomo A; Amore M; Vampini C; Fagiolini A Riv Psichiatr; 2021; 56(1):1-11. PubMed ID: 33560270 [TBL] [Abstract][Full Text] [Related]
13. Safety of long-term lamotrigine in epilepsy. Mackay FJ; Wilton LV; Pearce GL; Freemantle SN; Mann RD Epilepsia; 1997 Aug; 38(8):881-6. PubMed ID: 9579888 [TBL] [Abstract][Full Text] [Related]
14. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Steiner TJ; Dellaportas CI; Findley LJ; Gross M; Gibberd FB; Perkin GD; Park DM; Abbott R Epilepsia; 1999 May; 40(5):601-7. PubMed ID: 10386529 [TBL] [Abstract][Full Text] [Related]
15. Depression in patients with newly diagnosed epilepsy predicts lamotrigine-induced rash: a short-term observational study. Park SP Epilepsy Behav; 2013 Jul; 28(1):88-90. PubMed ID: 23673289 [TBL] [Abstract][Full Text] [Related]
16. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital]. Yamamoto T; Yamazoe T; Fujimoto A; Kobayashi R; Yokota T; Okanishi T; Uchiyama G; Ohashi T; Tanaka T; Enoki H Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132 [TBL] [Abstract][Full Text] [Related]
17. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population. Wang XQ; Lang SY; Shi XB; Tian HJ; Wang RF; Yang F Seizure; 2010 Nov; 19(9):562-6. PubMed ID: 20888266 [TBL] [Abstract][Full Text] [Related]
18. Adding lamotrigine to valproate: incidence of rash and other adverse effects. Postmarketing Antiepileptic Drug Survey (PADS) Group. Faught E; Morris G; Jacobson M; French J; Harden C; Montouris G; Rosenfeld W Epilepsia; 1999 Aug; 40(8):1135-40. PubMed ID: 10448828 [TBL] [Abstract][Full Text] [Related]
19. Lamotrigine as first-line drug in childhood absence epilepsy: a clinical and neurophysiological study. Coppola G; Licciardi F; Sciscio N; Russo F; Carotenuto M; Pascotto A Brain Dev; 2004 Jan; 26(1):26-9. PubMed ID: 14729411 [TBL] [Abstract][Full Text] [Related]